Suppr超能文献

饮酒与自身免疫性疾病

Alcohol Consumption and Autoimmune Diseases.

作者信息

Terracina Sergio, Caronti Brunella, Lucarelli Marco, Francati Silvia, Piccioni Maria Grazia, Tarani Luigi, Ceccanti Mauro, Caserta Micaela, Verdone Loredana, Venditti Sabrina, Fiore Marco, Ferraguti Giampiero

机构信息

Department of Experimental Medicine, Sapienza University of Rome, 00161 Rome, Italy.

Department of Human Neurosciences, Sapienza University Hospital of Rome, 00185 Rome, Italy.

出版信息

Int J Mol Sci. 2025 Jan 20;26(2):845. doi: 10.3390/ijms26020845.

Abstract

Alcohol is the second-most misused substance after tobacco. It has been identified as a causal factor in more than 200 diseases and 5.3% of all deaths and is associated with significant behavioral, social, and economic difficulties. As alcohol consumption may modulate the immune system's regulatory mechanisms to avoid attacking the body's tissues, it has been proven to play a dichotomic role in autoimmune diseases (ADs) based on the quantity of consumption. In this review, we report updated evidence on the role of alcohol in ADs, with a focus on alcohol addiction and the human biological immune system and the relationship between them, with alcohol as a risk or protective factor. Then, in this narrative review, we report the main evidence on the most studied ADs where alcohol represents a key modulator, including autoimmune thyroiditis, multiple sclerosis, rheumatoid arthritis, systemic lupus erythematosus, diabetes, allergic rhinitis, and primary biliary cholangitis. Alcohol at low-moderate dosages seems mostly to have a protective role in these diseases, while at higher dosages, the collateral risks surpass possible benefits. The specific mechanisms by which low-to-moderate alcohol intake relieves AD symptoms are not yet fully understood; however, emerging studies suggest that alcohol may have a systemic immunomodulatory effect, potentially altering the balance of anti-inflammatory innate and adaptive immune cells, as well as cytokines (via the NF-κB or NLRP3 pathways). It might influence the composition of the gut microbiome (increasing amounts of beneficial gut microbes) and the production of their fatty acid metabolites, such as short-chain fatty acids (SCFAs) and polyunsaturated fatty acids (PUFAs), as well as elevated concentrations of acetate, high-density lipoprotein (HDL), and nitric oxide (NO). Unfortunately, a definite acceptable daily intake (ADI) of ethanol is complicated to establish because of the many mechanisms associated with alcohol consumption such that despite the interesting content of these findings, there is a limit to their applicability and risks should be weighed in cases of alcoholic drinking recommendations. The aim of future studies should be to modulate those beneficial pathways involved in the alcohol-protective role of ADs with various strategies to avoid the risks associated with alcohol intake.

摘要

酒精是仅次于烟草的第二大滥用物质。它已被确定为200多种疾病的致病因素,占所有死亡人数的5.3%,并与重大的行为、社会和经济困难相关。由于饮酒可能调节免疫系统的调节机制以避免攻击身体组织,基于饮酒量,酒精已被证明在自身免疫性疾病(AD)中起双重作用。在本综述中,我们报告了关于酒精在AD中的作用的最新证据,重点关注酒精成瘾与人类生物免疫系统及其之间的关系,酒精作为风险或保护因素。然后,在本叙述性综述中,我们报告了关于研究最多的AD的主要证据,其中酒精是关键调节因子,包括自身免疫性甲状腺炎、多发性硬化症、类风湿性关节炎、系统性红斑狼疮、糖尿病、过敏性鼻炎和原发性胆汁性胆管炎。低至中等剂量的酒精似乎在这些疾病中大多具有保护作用,而在高剂量时,附带风险超过可能的益处。低至中等酒精摄入量缓解AD症状的具体机制尚未完全了解;然而,新出现的研究表明,酒精可能具有全身免疫调节作用,可能改变抗炎先天性和适应性免疫细胞以及细胞因子的平衡(通过NF-κB或NLRP3途径)。它可能影响肠道微生物群的组成(有益肠道微生物数量增加)及其脂肪酸代谢产物的产生,如短链脂肪酸(SCFA)和多不饱和脂肪酸(PUFA),以及乙酸盐、高密度脂蛋白(HDL)和一氧化氮(NO)浓度升高。不幸的是,由于与饮酒相关的机制众多,确定乙醇的明确每日可接受摄入量(ADI)很复杂,因此尽管这些发现内容有趣,但其适用性有限,在提出饮酒建议时应权衡风险。未来研究的目标应该是通过各种策略调节那些参与酒精对AD保护作用的有益途径,以避免与饮酒相关的风险。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6804/11766456/be7335774943/ijms-26-00845-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验